[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_1015 

# __Increased testing capacity and throughput__

## Articles mentionning this Benefit

* [Wastewater surveillance for population-wide Covid-19: The present and future](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_213.md)

## Category to which it belongs

* [Enhanced quantification, retrofitting of models, improved decision-making, cybersecurity, coordination, and testing efficiency for improved accuracy and awareness.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_5.md)

## Description of actual returns pertaining to this benefit

* [Private investors investing in pooled-sample analysis technologies can benefit from increased demand for testing services, potential contracts with healthcare systems, and financial returns from the implementation of these technologies.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_1140.md)

## Name of the Benefit

Pooled-sample analysis can greatly increase testing capacity and throughput, allowing for more efficient and widespread testing of populations.

## Risks which can benefit from this action

* [Pooled-sample analysis](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1021.md)

## Stakeholders benefitting from this Benefit

* [Healthcare systems](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_310.md)
* [Public health officials](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_193.md)

